Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas

Abstract

Sequential therapy with oral propranolol followed by topical timolol for IH may help minimize potential adverse effects of systemic beta-blockers by reducing the duration of propranolol therapy and facilitating successful taper at a younger age without an increase in treatment failures.